RAIN - Rain Therapeutics GAAP EPS of -$0.68 in-line November, 10 2022 04:32 PM Rain Therapeutics Inc. Rain Therapeutics press release ( NASDAQ: RAIN ): Q3 GAAP EPS of -$0.68 in-line. End of third quarter cash balance of $90.7 million excludes the $50.0 million registered offering For further details see: Rain Therapeutics GAAP EPS of -$0.68 in-line